The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> Infections

ABSTRACT Bacterial biofilms are responsible for a variety of serious human infections and are notoriously difficult to treat due to their recalcitrance to antibiotics. Further work is necessary to elicit a full understanding of the mechanism of this antibiotic tolerance. The arginine deiminase (ADI)...

Full description

Bibliographic Details
Main Authors: Jeffrey A. Freiberg, Yoann Le Breton, Janette M. Harro, Devon L. Allison, Kevin S. McIver, Mark E. Shirtliff
Format: Article
Language:English
Published: American Society for Microbiology 2020-08-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mBio.00919-20
_version_ 1818406298815823872
author Jeffrey A. Freiberg
Yoann Le Breton
Janette M. Harro
Devon L. Allison
Kevin S. McIver
Mark E. Shirtliff
author_facet Jeffrey A. Freiberg
Yoann Le Breton
Janette M. Harro
Devon L. Allison
Kevin S. McIver
Mark E. Shirtliff
author_sort Jeffrey A. Freiberg
collection DOAJ
description ABSTRACT Bacterial biofilms are responsible for a variety of serious human infections and are notoriously difficult to treat due to their recalcitrance to antibiotics. Further work is necessary to elicit a full understanding of the mechanism of this antibiotic tolerance. The arginine deiminase (ADI) pathway is responsible for bacterial pH maintenance and is highly expressed during biofilm growth in multiple bacterial species. Using the group A Streptococcus (GAS) as a model human pathogen, the ADI pathway was demonstrated to contribute to biofilm growth. The inability of antibiotics to reduce GAS populations when in a biofilm was demonstrated by in vitro studies and a novel animal model of nasopharyngeal infection. However, disruption of the ADI pathway returned GAS biofilms to planktonic levels of antibiotic sensitivity, suggesting the ADI pathway is influential in biofilm-related antibiotic treatment failure and provides a new strategic target for the treatment of biofilm infections in GAS and potentially numerous other bacterial species. IMPORTANCE Biofilm-mediated bacterial infections are a major threat to human health because of their recalcitrance to antibiotic treatment. Through the study of Streptococcus pyogenes, a significant human pathogen that is known to form antibiotic-tolerant biofilms, we demonstrated the role that a bacterial pathway known for responding to acid stress plays in biofilm growth and antibiotic tolerance. This not only provides some insight into antibiotic treatment failure in S. pyogenes infections but also, given the widespread nature of this pathway, provides a potentially broad target for antibiofilm therapies. This discovery has the potential to impact the treatment of many different types of recalcitrant biofilm infections.
first_indexed 2024-12-14T09:09:43Z
format Article
id doaj.art-927df0d4bc884f27a33bf54a25cb23bf
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-12-14T09:09:43Z
publishDate 2020-08-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-927df0d4bc884f27a33bf54a25cb23bf2022-12-21T23:08:35ZengAmerican Society for MicrobiologymBio2150-75112020-08-0111410.1128/mBio.00919-20The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> InfectionsJeffrey A. Freiberg0Yoann Le Breton1Janette M. Harro2Devon L. Allison3Kevin S. McIver4Mark E. Shirtliff5Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, Maryland, USADepartment of Cell Biology &amp; Molecular Genetics and Maryland Pathogen Research Institute, University of Maryland, College Park, Maryland, USADepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, Maryland, USADepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, Maryland, USADepartment of Cell Biology &amp; Molecular Genetics and Maryland Pathogen Research Institute, University of Maryland, College Park, Maryland, USADepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, Maryland, USAABSTRACT Bacterial biofilms are responsible for a variety of serious human infections and are notoriously difficult to treat due to their recalcitrance to antibiotics. Further work is necessary to elicit a full understanding of the mechanism of this antibiotic tolerance. The arginine deiminase (ADI) pathway is responsible for bacterial pH maintenance and is highly expressed during biofilm growth in multiple bacterial species. Using the group A Streptococcus (GAS) as a model human pathogen, the ADI pathway was demonstrated to contribute to biofilm growth. The inability of antibiotics to reduce GAS populations when in a biofilm was demonstrated by in vitro studies and a novel animal model of nasopharyngeal infection. However, disruption of the ADI pathway returned GAS biofilms to planktonic levels of antibiotic sensitivity, suggesting the ADI pathway is influential in biofilm-related antibiotic treatment failure and provides a new strategic target for the treatment of biofilm infections in GAS and potentially numerous other bacterial species. IMPORTANCE Biofilm-mediated bacterial infections are a major threat to human health because of their recalcitrance to antibiotic treatment. Through the study of Streptococcus pyogenes, a significant human pathogen that is known to form antibiotic-tolerant biofilms, we demonstrated the role that a bacterial pathway known for responding to acid stress plays in biofilm growth and antibiotic tolerance. This not only provides some insight into antibiotic treatment failure in S. pyogenes infections but also, given the widespread nature of this pathway, provides a potentially broad target for antibiofilm therapies. This discovery has the potential to impact the treatment of many different types of recalcitrant biofilm infections.https://journals.asm.org/doi/10.1128/mBio.00919-20Streptococcus pyogenesantibiotic tolerancearginine deiminasebiofilmsgroup A Streptococcus
spellingShingle Jeffrey A. Freiberg
Yoann Le Breton
Janette M. Harro
Devon L. Allison
Kevin S. McIver
Mark E. Shirtliff
The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> Infections
mBio
Streptococcus pyogenes
antibiotic tolerance
arginine deiminase
biofilms
group A Streptococcus
title The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> Infections
title_full The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> Infections
title_fullStr The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> Infections
title_full_unstemmed The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> Infections
title_short The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated <named-content content-type="genus-species">Streptococcus pyogenes</named-content> Infections
title_sort arginine deiminase pathway impacts antibiotic tolerance during biofilm mediated named content content type genus species streptococcus pyogenes named content infections
topic Streptococcus pyogenes
antibiotic tolerance
arginine deiminase
biofilms
group A Streptococcus
url https://journals.asm.org/doi/10.1128/mBio.00919-20
work_keys_str_mv AT jeffreyafreiberg theargininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT yoannlebreton theargininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT janettemharro theargininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT devonlallison theargininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT kevinsmciver theargininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT markeshirtliff theargininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT jeffreyafreiberg argininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT yoannlebreton argininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT janettemharro argininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT devonlallison argininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT kevinsmciver argininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections
AT markeshirtliff argininedeiminasepathwayimpactsantibiotictoleranceduringbiofilmmediatednamedcontentcontenttypegenusspeciesstreptococcuspyogenesnamedcontentinfections